2. Adjuvant
  3. Targeted Pattern Recognition Receptor-Type Adjuvants
  4. STING Adjuvant

STING Adjuvant

STING Adjuvant (3):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-12885
    2’3’-c-di-AM(PS)2 (Rp,Rp) 1638241-89-0 99.85%
    2’3’-c-di-AM(PS)2 (Rp,Rp) (ADU-S100), an activator of stimulator of interferon genes (STING), leads to potent and systemic tumor regression and immunity.
    2’3’-c-di-AM(PS)2 (Rp,Rp)
  • HY-12326B
    c-di-AMP diammonium 99.36%
    c-di-AMP diammonium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c-di-AMP diammonium is also a bacterial second messenger, which regulates cell growth, survival, and virulence, primarily within Gram-positive bacteria, and also regulates host immune response. c-di-AMP diammonium acts as a potent mucosal adjuvant stimulating both humoral and cellular responses.
    c-di-AMP diammonium
  • HY-139586
    Ulevostinag 2082743-96-0 98.05%
    Ulevostinag (MK-1454) is a potent cyclic dinucleotide agonist stimulator of interferon genes (STING). Ulevostinag (MK-1454) acts in the intra-tumoral route by targeting the stimulator of interferon genes (STING) protein. Ulevostinag (MK-1454) can be used for immuno-tumor cancer disease research.
    Ulevostinag